Defining Best Practice in Research Procurement

In November 2022 over 400 attendees from the buy and sell side joined us in London to debate how the research market will react to the discontinuation of the SEC no action relief, how innovation and consolidation among research providers will change supply dynamics, and how the increasingly data-driven investment functions will affect what is demanded from brokers and IRPs.

On June 14th 2023 we will reunite the North American investment research industry at the Metropolitan Club, New York – panels will cover how the end of the SEC no action relief will now play out, where corporate access has levelled out post-lockdowns, how a volatile market climate is affecting the external research and data that asset managers need to consume, and how budgeting and valuation has evolved as a result.

Our event has almost sold out, if you are a buyside representative please email [email protected] for a complimentary ticket and for all other attendees please purchase your ticket below.

Speakers include:

Alex Andronov, Global Head of Business Development, HSBC
Jim Bode, Global Head of Broker Relations, AlphaSense
Ryan Brier, General Manager, Stream by Alphasense
Tracy Caliendo, Head of Global Commission Management and Hedge Fund Services, Bank of America
Douglas Christensen, Head of Capital Market Solutions, SS&C Tier1
Swaroopa Desai, Head of Corporate Access, Cowen
Simon Edwards, Head of Business Development, BlueMatrix
Lauren Fochesto, Director of Broker Relations, Glenview Capital
Amrish Ganatra, Chief Executive Officer, Commcise
Lauren Giametta, Director, Research Management, BlackRock
Matt Garvie, Vice President, Investor Relations, U.S. Xpress
Bryan Healey, CTO, Aiera
Robin Hodgkins, President, Castine LLC
Stuart Howard, Global Head of Research Relationships, Invesco
Todd Klein, Head of US Operations, Singletrack
Thomas Li, Co-founder & CEO, Daloopa
Brijesh Malkan, Chief Strategy Officer, Singletrack
Joshua Maxey, CMO & Co-Founder, Third Bridge
Michael Mayhew, Chairman, Integrity Research Associates
Mike McCarthy, Head of Global Research Support, Fidelity Management & Research
Jeff McLaughlin, Director, Investor Relations, GSK
Rob Mohan, Managing Director, Wellington Management
Steve Moreno, Global Research Relationship Manager, Capital Group
Lauren Mullen, Executive Director and Assistant General Counsel, J.P. Morgan
Virendra Naykude, General Manager, Eidosmedia USA
Mark Pellegrino, CEO, CorpAxe
Kevin Petrello, S&P Global
John E. Pflieger, Jr., Global Head of External Research Services, T. Rowe Price
Jack Pollina, Managing Director, Virtu Financial
Lindsey Reardon, Director, Global Research Services & Corporate Access, Wellington Management
Neil Scarth, Principal, Frost Consulting
Aniket Shah, Global Head of ESG and Sustainable Finance Research, Jefferies
Steve Stone, Partner, Morgan Lewis & Bockius LLP
Pam Torres, General Counsel of Global Investment Research, Goldman Sachs
Vesna Tosic, Associate Director, Investor Relations, Regeneron

Coffee & Registration
8.30 – 9.00 EST

Welcome: Mike Carrodus, Chief Executive Officer
09.00 EST

Panel I: The Evolution of the Research Budget
9:10 EST

Buy side firms are increasingly confident in their research valuation processes, which are now reflecting the changes in market climate and resulting changes in demand from their investment teams. What does the research budget look like in 2023, and how is the allocation of that budget and the consumption of research by asset managers changing?

Moderator: Mike Carrodus, CEO, Substantive Research
Speakers: Stuart Howard, Global Head of Research Relationships, Invesco
Amrish Ganatra,
Chief Executive Officer, Commcise
Lauren Giametta,
Director, Research Services, Blackrock
John E. Pflieger, Jr.,
Global Head of External Research Services, T. Rowe Price
Douglas Christensen
, VP, Head of Capital Market Solutions, Tier1 | SS&C

Coffee Break
10:00 EST

Panel II: The Regulatory Outlook – Life after the SEC No Action Relief
10:30 EST

Of all the regulatory news that has hit the research market in the last few months, the discontinuation of the no action relief covering hard dollar payments from Europe to US brokers is the one that will fundamentally impact the market. 11 months on from the SEC’s surprise announcement, and with a month to go before the deadline (unless Congress ensures that it’s actually 6 months to go now!), there is still no clear solution in place that buy and sell side firms can adopt now. Which options are available and viable? What does a firm’s choice of approach depend on? How does this all affect wider discussion on the future of research funding and payments?

Moderator: Mike Carrodus, CEO, Substantive Research
Speakers: Steve Stone, Partner, Morgan Lewis & Bockius LLP
Lauren Mullen,
Executive Director and Assistant General Counsel, J.P. Morgan
Robin Hodgkins,
President, Castine LLC
Jack Pollina
, Managing Director, Virtu Financial
Pam Torres, General Counsel of Global Investment Research, Goldman Sachs

Panel III: The Research Product
11:20 EST

Market volatility in 2023 is giving the post-lockdown model of packaging and delivery of research a thorough stress test. As pricing in this market stabilises and perhaps even begins increasing again for some providers, asset managers increasingly forensic assessment of the value of their analysis and services is ensuring clear winners and losers. And the buy side’s focus on data, plus ESG now driving asset gathering brings even more demands and potential opportunity for providers to increase their market share and gain new footholds. Can a stand alone research business still make money in this market, or is the only option ahead to be part of a broad offering that doesn’t need to rely on research revenues only?

Moderator: Michael Mayhew, Chairman, Integrity Research Associates
Speakers: Todd Klein, Head of US Operations, Singletrack
Simon Edwards,
Chief Revenue Officer, BlueMatrix
Tracy Caliendo,
Head of Global Commission Management and Hedge Fund Services, Bank of America
Joshua Maxey,
Co-founder & CRO, ThirdBridge
Thomas Li,
Co-founder & CEO, Daloopa
Ryan Brier, General Manager, Stream by Alphasense

Lunch
12:10 EST

Panel IV: The Integration of Research and Data
13:40 EST

Given that data and analytics are increasingly incorporated into alternative and long only managers’ internal processes, how is supply and demand for external research adapting to align with this trend? How have brokers adapted and repackaged research for their clients’ more data driven approaches, and how is the buy side delineating research and market data budgets given this overlapping trend? Research budgets have decreased whilst data budgets keep growing, but is this an ongoing trend for the long term?

Moderator: Mike Carrodus, CEO, Substantive Research
Speakers: Robert Mohan, Managing Director, Wellington
Aniket Shah,
Global Head of ESG Research and Sustainability Strategy, Jefferies
Jim Bode,
Global Head of Broker Relations, AlphaSense
Steve Moreno, Global Research Relationship Manager, Capital Group
Virendra Naykude, General Manager, Eidosmedia USA

Coffee Break
14:30 EST

Panel V: Corporate Access in a Post-Lockdown World
15:00 EST

As we emerge from lockdowns it feels like everything and nothing has changed. The sell side has reasserted its role as a key intermediary, while virtual interactions have emboldened many buy side firms to contact and communicate with companies directly. On the other hand, virtual meetings have completely changed people’s propensity to travel, and there is now a forensic focus on which engagements need to be face to face. What differentiates the sell side’s corporate access services in the new hybrid world? If more asset managers are going direct how are they doing it and what is the feedback from corporates? If you aren’t a large long only then how should you approach your corporate access program in order to ensure your investment process still works in 2023? How are corporates approaching their IR differently now, and what would help them most from brokers and the buy side?

Moderator: Mike Carrodus, CEO, Substantive Research
Speakers: Mark Pellegrino,
CEO, CorpAxe
Swaroopa Desai, Head of Corporate Access, Cowen
Bryan Healey, CTO, Aiera
Matt Garvie, Vice President, Investor Relations, U.S. Xpress
Vesna Tosic, Associate Director, Investor Relations, Regeneron
Jeff McLaughlin, Director, Investor Relations, GSK

Panel VI: Research Valuation – How aligned are Buy and Sell Side processes?
15:50 EST

How do buy and sell side research valuation processes compare when you look at them in detail? How can they become more aligned to ensure providers invest in areas that deliver the greatest value? How close are both sides to agreeing on one set of data to define how valuable each relationship is to both parties?

Moderator: Brijesh Malkan, Chief Strategy Officer, Singletrack
Speakers: Alex Andronov, Global Head of Business Development, Global Research, HSBC
Lindsey Reardon,
Director, Global Research Services & Corporate Access, Wellington Management
Neil Scarth, Principal, Frost Consulting
Kevin Petrello, S&P Global

Lauren Fochesto, Director of Broker Relations, Glenview Capital

Cocktail Reception
4:40 EST

*tbc